About
Lobeglitazone is an oral antidiabetic agent belonging to the thiazolidinedione (TZD) class, specifically designed for the management of type 2 diabetes mellitus. It acts as a potent and selective agonist for peroxisome proliferator-activated receptor gamma (PPARγ), a nuclear receptor primarily expressed in adipose tissue, skeletal muscle, and liver. Activation of PPARγ leads to increased insulin sensitivity in peripheral tissues and the liver, thereby improving glucose uptake and utilization. This fundamental mechanism helps to directly address and reduce insulin resistance, a core pathophysiological defect in type 2 diabetes, and consequently lowers blood glucose levels.
By enhancing the body's response to insulin, lobeglitazone not only improves glycemic control but also exerts beneficial effects on lipid profiles, such as reducing triglycerides and increasing high-density lipoprotein (HDL) cholesterol. Its action helps to preserve pancreatic beta-cell function over time, contributing to sustained glycemic management. Lobeglitazone is typically used as an adjunct to diet and exercise, either as monotherapy or in combination with other antidiabetic agents, to achieve optimal blood sugar control.
Uses
- Treatment of type 2 diabetes mellitus.
- To improve glycemic control in adults.
- Used as monotherapy or in combination with other antidiabetic agents.
- As an adjunct to diet and exercise.
Directions For Use
Take this medication orally, once daily, with or without food, as prescribed by your healthcare provider. Do not crush or chew the tablet.
Benefits
- Significantly improves insulin sensitivity.
- Effectively lowers blood glucose levels.
- Reduces HbA1c levels.
- May improve lipid profiles.
- Provides sustained glycemic control.
- Reduces hepatic glucose output.
Side Effects
- Fluid retention (edema)
- Weight gain
- Headache
- Upper respiratory tract infection
- Anemia
- Dizziness
- Hypoglycemia (when used with insulin or sulfonylureas)
- Macular edema (rare)
- Bone fractures (especially in women)
- Liver enzyme elevation (rare)
- Heart failure (exacerbation)
- Bladder cancer (rare, long-term use)
Safety Measures
- Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake may increase the risk of hypoglycemia or liver issues.
- Pregnancy - Not recommended during pregnancy. Animal studies show potential fetal harm. Use only if the potential benefit justifies the potential risk to the fetus.
- Breastfeeding - Avoid use during breastfeeding as it is unknown if lobeglitazone is excreted in human milk and could pose risks to the infant.
- Liver - Contraindicated in patients with active liver disease or elevated liver enzymes. Regular monitoring of liver function tests is essential.
- Kidney - Generally considered safe for use in patients with renal impairment, as it is primarily metabolized by the liver. No dose adjustment typically needed.
- Lung - Use with caution in patients with pre-existing heart failure or conditions that predispose to fluid retention, as it can exacerbate these.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!